XENETIC BIOSCIENCES INC (XBIO) Stock Cash Flow
NASDAQ:XBIO - Nasdaq - US9840156023 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -3.96M | -4.13M | -6.55M | -5.65M | -10.89M | |||
| Depreciation Amortization | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | -2.92M | |||
| Change In Working Capital | 971.00K | -262.70K | -430.00K | 460.00K | -50.00K | |||
| Other non cash items | 171.80K | 283.10K | 2.33M | 450.00K | 9.60M | |||
| OPERATING CASH FLOW | -2.82M | -4.11M | -4.65M | -4.74M | -4.27M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -500.00K | N/A | N/A | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | N/A | 0.00 | -500.00K | N/A | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | N/A | 0.00 | 11.45M | 5.43M | |||
| FINANCING CASH FLOW | N/A | N/A | 0.00 | 11.45M | 5.43M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -2.82M | -4.11M | -5.15M | 6.72M | 1.16M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -2.82M | -4.11M | -4.65M | -4.74M | -4.27M | |||
| Capital Expenditure | N/A | 0.00 | -500.00K | N/A | N/A | |||
| FREE CASH FLOW | -2.82M | -4.11M | -5.15M | -4.74M | -4.27M | |||
All data in USD